U.S. Sen. Ted Cruz (R-Texas) today issued the following statement following the decision by the Food and Drug Administration (FDA) to further restrict monoclonal antibody treatments produced by Eli Lilly and Regeneron: “The Biden administration’s track record on COVID is […]

Read More »